ArticleERJ open research2025

Respiratory infections after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis: analysis of the European Cystic Fibrosis Society Patient Registry.

Mordechai Pollak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.